Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.000 -0.080 (-2.60%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Ardelyx: Q4 Earnings Insights ↗

February 28, 2022

Ardelyx (NASDAQ:ARDX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Ardelyx...

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Earnings Preview: Ardelyx ↗

February 25, 2022

Ardelyx (NASDAQ:ARDX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

23 Stocks Moving in Wednesday's Pre-Market Session ↗

February 02, 2022

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Also check out: Executives buy more than $600 million of 3...

Via Benzinga

ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 10, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

52 Weeks High And Low Article ↗

February 11, 2022

On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 09, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) shares increased by 88.08% to $5.61 during Thursday's regular session. As of 12:30 EST, Ensysce Biosciences's stock is...

Via Benzinga

20 Stocks Moving in Monday's Pre-Market Session ↗

December 06, 2021

Gainers CF Acquisition Corp. VI (NASDAQ: CFVI) rose 23.6% to $14.75 in pre-market trading on continued strength following the SPACs announcement of a merger with Rumble. Digital...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 02, 2021

Gainers Biofrontera (NASDAQ:BFRI) shares ...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 01, 2021

Gainers Ardelyx (NASDAQ:ARDX) shares rose 25.87% to $1.44 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 215.1 million...

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

CRM Stock: 9 Reasons Why Salesforce Shares Are Sliding Lower Today ↗

December 01, 2021

Salesforce (CRM) stock is falling on Wednesday following the release of the e-commerce company's Q3 fiscal 2022 earnings report.

Via InvestorPlace

50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 01, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...

Via Benzinga

Topics Intellectual Property

ARDX Stock Alert: The IBS Drug News Sending Ardelyx Shares Soaring Today ↗

December 01, 2021

Ardelyx (ARDX) stock is soaring higher on Wednesday following an update concerning the company's ISB-C treatment in adults.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021 ↗

December 01, 2021

Upgrades Goldman Sachs upgraded the previous rating for Grupo Aeroportuario del Sureste SAB de CV

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 01, 2021

Gainers Ardelyx (NASDAQ:ARDX) stock increased by 19.29% to $1.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $153.3...

Via Benzinga

Citi, Ladenburg React Positively On Ardelyx's IBS-C Treatment Launch Plans ↗

December 01, 2021

Citigroup

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 01, 2021

Good morning, traders! We're starting off the day right with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

23 Stocks Moving in Wednesday's Pre-Market Session ↗

December 01, 2021

Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a...

Via Benzinga

Ardelyx's Return On Capital Employed Insights ↗

November 12, 2021

According to Benzinga Pro data, during Q3, Ardelyx (NASDAQ:ARDX) posted sales of $1.17 million. Earnings were up 5.79%, but Ardelyx still reported an overall loss of $42.24...

Via Benzinga

Ardelyx, Inc. (NASDAQ:ARDX) Long Term Shareholder Notice: Investigation of Potential Wrongdoing ↗

October 28, 2021

San Diego, CA -- (SBWIRE) -- 10/28/2021 -- Certain directors of Ardelyx, Inc are under investigation over possible breaches of fiduciary duties.

Via SBWire

Topics Lawsuit

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 26, 2021

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 20, 2021

Gainers Tenet Healthcare (NYSE:THC) stock r...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 15, 2021

Gainers Statera BioPharma (NASDAQ:STAB) shares rose 16.9% to $3.32 during Friday's regular session. The market value of their outstanding shares is at $91.7 million....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 ↗

October 14, 2021

Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 13, 2021

Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $87....

Via Benzinga

Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Ardelyx Inc. Investors in Securities Fraud Class Action Lawsuit

September 30, 2021

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

CLASS ACTION UPDATE for ARDX, ANVS and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

September 28, 2021

NEW YORK, NY / ACCESSWIRE / September 28, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Lawsuit

SHAREHOLDER ALERT: ARDX LIVE SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

September 28, 2021

NEW YORK, NY / ACCESSWIRE / September 28, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered...

From The Law Offices of Vincent Wong

Via AccessWire

Topics Fraud

LAWSUITS FILED AGAINST ARDX, HYRE and WDH - Jakubowitz Law Pursues Shareholders Claims

September 27, 2021

NEW YORK, NY / ACCESSWIRE / September 27, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Initial Public Offering Lawsuit

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.